Astonea Labs IPO
IPO Details
Astonea Labs IPO is a bookbuilding of ₹37.67 Crore. The issue is entirely a fresh issue of ₹37.67 Crore and an offer for sale of Nil.
Astonea Labs IPO opens for subscription on 2025-05-27 and closes on 2025-05-29. The allotment is expected to be finalized on 2025-05-30. The IPO will be listed on BSE, NSE with tentative listing date as 2025-06-03.
Price band is set at ₹128 to ₹135 per share. The minimum lot size for application is 1000 shares (₹128000). It is suggested to bid at the cutoff price to avoid oversubscription, which is about ₹135000.
IPO Timeline
Company Overview
Astonea Labs IPO Details
Astonea Labs Limited is a Haryana-based pharmaceutical and cosmetic product manufacturer, offering formulations across multiple therapeutic segments. Established in 2017, the company has seen robust financial growth and aims to scale operations through this IPO.
Company Overview
Founded in April 2017, Astonea Labs manufactures:
- Tablets, capsules, powders
- Ointments, creams, and lotions
Their facility spans 7,500 sq. meters and meets Drug and Cosmetic Act standards.
Business Segments
- Pharmaceuticals: Includes anti-cold, anti-fungal, cardiovascular, diabetes, gynecology, and pain relief products.
- Cosmetics: Covers skin, dental, and hair care products such as lotions, gels, serums, and creams.
Financial Highlights
| Year | Revenue (₹ Cr) | PAT (₹ Cr) | PAT Margin (%) | EPS (₹) | ROE (%) |
|---|---|---|---|---|---|
| FY22 | 30.17 | 0.25 | 0.83 | - | - |
| FY23 | 67.26 | 0.67 | 1.00 | - | - |
| FY24 | 80.29 | 3.81 | 4.75 | 5.01 | 37.86 |
| FY24 (9M) | 69.69 | 4.10 | 5.89 | - | - |
IPO Details
- Issue Size: ₹37.67 Cr (Fresh Issue Only)
- Price Band: ₹128 - ₹135
- Lot Size: 1,000 shares
- Minimum Investment: ₹1,35,000
- Listing Exchange: BSE SME
- GMP: ₹18 (13.33%)
IPO Timeline
- Opens: May 27, 2025
- Closes: May 29, 2025
- Allotment: May 30, 2025
- Listing: June 3, 2025
IPO Objectives
- Drug registration in South America
- Machinery for ointment manufacturing
- Advertising and brand building
- Software and hardware procurement
- Working capital
- General corporate purposes
Subscription Allocation
| Category | Allocation |
|---|---|
| QIB | 50% |
| NII | 15% |
| Retail | 35% |
Strengths
- Strong presence in both pharma and cosmetics
- Rapid revenue and profit growth
- Manufacturing facility with global compliance
- Strategic export focus
Risks
- Dependency on third-party suppliers
- Regulatory delays
- High competition
- Foreign currency risks
Lead Manager & Registrar
- LM: Oneview Corporate Advisors Pvt Ltd
- Registrar: KFin Technologies Limited
Disclaimer: This document is for informational purposes only. Investors should consult financial experts before investing.
Business Segments
Information about business segments will be available soon.
Financial Performance
| Particulars | FY 2022 | FY 2023 | FY 2024 | FY 2024 (9m) |
|---|---|---|---|---|
| debtequity | 2.16 | |||
| ebitda margin | % | % | 14.6% | % |
| eps | ₹ | ₹ | 5.01 ₹ | ₹ |
| nav | ₹ | ₹ | 15.75 ₹ | ₹ |
| pat | ₹0.25 Cr | ₹0.67 Cr | ₹3.81 Cr | ₹4.1 Cr |
| pat margin | 0.83% | 1% | 4.75% | 5.89% |
| revenue | ₹30.17 Cr | ₹67.26 Cr | ₹80.29 Cr | ₹69.69 Cr |
| roce | % | % | 22.95% | % |
| roe | % | % | 37.86% | % |
* Percentage values represent margins
Additional Information
The proceeds from the IPO will be used for:
- Expansion of manufacturing facilities
- Debt repayment
- General corporate purposes
Information about key strengths will be available soon.
Information about risk factors will be available soon.
| Category | Allocation | Subscription |
|---|---|---|
| QIB | 50% | TBA |
| NII | 15% | TBA |
| Retail | 35% | TBA |
| Total | 100% | TBA |
Industry analysts are positive about the company's growth prospects given its strong financial performance, diversified product portfolio, and expansion plans. The IPO is expected to receive good response from investors looking for exposure to the sector.
Grey Market Premium
*Expected Premium is derived from market rumors. It is not a guaranteed indicator of the actual listing price.
IPO Quick Info
Market Lot
IPO Details
Lead Managers
- Axis Capital Limited
- ICICI Securities Limited
- Kotak Mahindra Capital Company Limited
Registrar
Link Intime India Private Limited
